You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (18)

Journals (0)

1-10 of 18 results for live biotherapeutics

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Live Biotherapeutic Products for the Prevention of Recurrent Clostridioides difficile Infection

Retricted access

Review article

First published 2024-12

Live Biotherapeutic Products for the Prevention of Recurrent Clostridioides difficile Infection

Natasha N. Pettit, Kristy M. Shaeer, Elias B. Chahine

Annals of Pharmacotherapy

Select article: Living Biotherapeutics Explore New Niches

Retricted access

Research article

First published 2021-8

Living Biotherapeutics Explore New Niches

Gail Dutton

Genetic Engineering & Biotechnology News

Select article: Microbiota restoration therapies for recurrent Clostridioides difficile infection reach an important new milestone

Open access

Review article

First published 2024

Microbiota restoration therapies for recurrent Clostridioides difficile infection reach an important new milestone

Herbert L. DuPont, Andrew W. DuPont, Glenn S. Tillotson

Therapeutic Advances in Gastroenterology

Select article: Corrigendum to “Live Biotherapeutic Products for the Prevention of Recurrent Clostridioides difficile Infection”

Retricted access

Correction

First published 2025-9

Corrigendum to “Live Biotherapeutic Products for the Prevention of Recurrent Clostridioides difficile Infection”

Annals of Pharmacotherapy

Select article: Retrospective subgroup analysis of fecal microbiota,live-jslm (REBYOTA ® ) administered by colonoscopy under enforcement discretion for the prevention of recurrent Clostridioides difficile infection

Open access

Brief report

First published 2024

Retrospective subgroup analysis of fecal microbiota,live-jslm (REBYOTA ® ) administered by colonoscopy under enforcement discretion for the prevention of recurrent Clostridioides difficile infection

Whitfield L. Knapple, David S. Yoho, Alexander Sheh [...]

Therapeutic Advances in Gastroenterology

Select article: Testing a Fast-dissolving Tablet Containing a Recombinant Live Biotherapeutic Product,MucoCept-CVN,in the Non-human Primate Model for Colonization

Retricted access

Abstract

First published 2014-10

Testing a Fast-dissolving Tablet Containing a Recombinant Live Biotherapeutic Product,MucoCept-CVN,in the Non-human Primate Model for Colonization

Laurel Lagenaur, Peter Lee, Thomas Parks

AIDS Research and Human Retroviruses

Select article: Safety of fecal microbiota,live-jslm (REBYOTA ™ ) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials

Open access

Research article

First published 2023

Safety of fecal microbiota,live-jslm (REBYOTA ™ ) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials

Christine Lee, Thomas Louie, Lindy Bancke [...]

Therapeutic Advances in Gastroenterology

Select article: Prevention of recurrent Clostridioides difficile infection by fecal microbiota,live-jslm (REBYOTA ® ) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial

Open access

Research article

First published 2025

Prevention of recurrent Clostridioides difficile infection by fecal microbiota,live-jslm (REBYOTA ® ) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial

Sahil Khanna, David Yoho, Daniel Van Handel [...]

Therapeutic Advances in Gastroenterology

Select article: Safety and effectiveness of fecal microbiota,live-jslm (REBYOTA ® ) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE,a single-arm,phase IIIb trial

Open access

Research article

First published 2025

Safety and effectiveness of fecal microbiota,live-jslm (REBYOTA ® ) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE,a single-arm,phase IIIb trial

Sahil Khanna, David Yoho, Daniel Van Handel [...]

Therapeutic Advances in Gastroenterology

Select article: Systematic review of the orally administered microbiome therapeutic,fecal microbiota spores,live-brpk,to prevent recurrence of Clostridioides difficile infection in adults

Open access

Review article

First published 2024

Systematic review of the orally administered microbiome therapeutic,fecal microbiota spores,live-brpk,to prevent recurrence of Clostridioides difficile infection in adults

Kerry LaPlante, Robert Stevens, Anne J Gonzales-Luna

Sage Open Medicine

1
2
10 / page

Article type

Publication date

Subjects

Access